GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambalal Sarabhai Enterprises Ltd (BOM:500009) » Definitions » EV-to-EBIT

Ambalalrabhai Enterprises (BOM:500009) EV-to-EBIT : 29.54 (As of Jun. 23, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ambalalrabhai Enterprises EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ambalalrabhai Enterprises's Enterprise Value is ₹3,650 Mil. Ambalalrabhai Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹124 Mil. Therefore, Ambalalrabhai Enterprises's EV-to-EBIT for today is 29.54.

The historical rank and industry rank for Ambalalrabhai Enterprises's EV-to-EBIT or its related term are showing as below:

BOM:500009' s EV-to-EBIT Range Over the Past 10 Years
Min: -73.13   Med: 8.08   Max: 118.65
Current: 29.54

During the past 13 years, the highest EV-to-EBIT of Ambalalrabhai Enterprises was 118.65. The lowest was -73.13. And the median was 8.08.

BOM:500009's EV-to-EBIT is ranked worse than
73.76% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.05 vs BOM:500009: 29.54

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ambalalrabhai Enterprises's Enterprise Value for the quarter that ended in Mar. 2024 was ₹3,680 Mil. Ambalalrabhai Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹124 Mil. Ambalalrabhai Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 3.36%.


Ambalalrabhai Enterprises EV-to-EBIT Historical Data

The historical data trend for Ambalalrabhai Enterprises's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambalalrabhai Enterprises EV-to-EBIT Chart

Ambalalrabhai Enterprises Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.82 3.84 4.81 10.09 29.79

Ambalalrabhai Enterprises Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.09 16.93 24.97 24.03 29.79

Competitive Comparison of Ambalalrabhai Enterprises's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Ambalalrabhai Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambalalrabhai Enterprises's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambalalrabhai Enterprises's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ambalalrabhai Enterprises's EV-to-EBIT falls into.



Ambalalrabhai Enterprises EV-to-EBIT Calculation

Ambalalrabhai Enterprises's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3649.616/123.534
=29.54

Ambalalrabhai Enterprises's current Enterprise Value is ₹3,650 Mil.
Ambalalrabhai Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹124 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambalalrabhai Enterprises  (BOM:500009) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ambalalrabhai Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=123.534/3679.555484
=3.36 %

Ambalalrabhai Enterprises's Enterprise Value for the quarter that ended in Mar. 2024 was ₹3,680 Mil.
Ambalalrabhai Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹124 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambalalrabhai Enterprises EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ambalalrabhai Enterprises's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ambalalrabhai Enterprises (BOM:500009) Business Description

Traded in Other Exchanges
N/A
Address
Mirzapur Road, Shanti Sadan, Ahmedabad, GJ, IND, 380001
Ambalal Sarabhai Enterprises Ltd is an India-based company engaged in the manufacturing and marketing of Drugs and Formulation. Its operating segments are Pharmaceutical Products. It serves domestic as well as international markets.

Ambalalrabhai Enterprises (BOM:500009) Headlines

No Headlines